AzTrials
AzTrials

Colostomy - StomaNCT07206836

Pediatric Colostomy Reversal: Traditional Care vs. Enhanced Recovery After Surgery

A study testing Enhanced Recovery after Surgery Protocol and Traditional Care Protocol in people with Colostomy - Stoma and Stoma Reversal Procedure, run by Children Hospital Faisalabad at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn whether using an Enhanced Recovery After Surgery (ERAS) protocol helps children recover faster after colostomy reversal compared with traditional care. Read more about this study

Who is it for?
Ages 2 to 13 years
Conditions the study is for
Colostomy - Stoma, Stoma Reversal Procedure, ERAS
What is being tested?
Enhanced Recovery after Surgery Protocol and Traditional Care Protocol
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 sitePakistan
Study dates
1 Aug 2025to Nov 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Patients with Colostomy
  • Admitted for Reversal of colostomy

Who cannot join

  • Patients with endocrinal abnormalities
  • Patients with cardiac abnormalities
  • Patients with spinal abnormalities
  • Patients with bleeding abnormalities
  • Patients who have undergone previous multiple abdominal surgeries

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Salman Ali, MBBS contact

+923000680882

SalmanAli@live.com

Pakistan1 site, 1 recruiting
  • Children Hospital and Institute of Child Health Faisalabad

    Faisalābad, Punjab Province

    Naveed Irshad, MBBS, +92 334 0671331

    Recruiting

Other trials in Pakistan

About this study

Official title: Comparison of Outcome of Colostomy Reversal in Pediatric Patients With Enhanced Recovery After Surgery Versus Traditional Care Protocols.

The goal of this clinical trial is to learn whether using an Enhanced Recovery After Surgery (ERAS) protocol helps children recover faster after colostomy reversal compared with traditional care.

The main question it aims to answer is:

Read more

Does ERAS lower the number of days children need to stay in the hospital after colostomy reversal compared with traditional care?

Researchers will compare two groups:

ERAS group - Children receive shorter pre-surgery fasting, no mechanical bowel preparation, early pain control, and early feeding after surgery.

Traditional care group - Children receive the usual long bowel preparation, overnight fasting, opioid pain medicine, and a longer period without food after surgery.

Participants will:

Be randomly assigned to either the ERAS or traditional care group

Have their colostomy surgically closed by experienced pediatric surgeons

Be monitored daily until they can eat a solid meal without vomiting; this marks the end of their hospital stay

The study will enroll 60 children ages 2-13 at Children's Hospital Faisalabad, Pakistan.

Researchers will measure length of hospital stay from surgery until discharge as the main outcome.

Read the detailed description

This single-center, prospective randomized controlled trial will compare two perioperative care strategies for pediatric colostomy reversal: the Enhanced Recovery After Surgery (ERAS) protocol and the conventional Traditional Care Protocol (TCP). The study is being conducted in the Department of Pediatric Surgery at the Children's Hospital and Institute of Child Health, Faisalabad, Pakistan.

Scientific Rationale

Colostomy reversal restores bowel continuity after temporary fecal diversion, which is frequently performed in children with anorectal malformations (ARM), Hirschsprung's disease (HD), or following severe perineal injury. Conventional postoperative care has historically included three days of mechanical bowel preparation, prolonged pre-operative fasting, routine nasogastric decompression, opioid-based analgesia, and delayed oral feeding. Evidence from both adult and pediatric literature shows that ERAS protocols-emphasizing minimal bowel preparation, shortened fasting, multimodal non-opioid analgesia, and early enteral feeding-can reduce hospital stay and enhance recovery without increasing complications. However, high-quality pediatric data, especially from South Asia, remain limited.

Study Design

The trial will enroll 60 children (ages 2-13 years) who meet inclusion criteria and have no major comorbidities or prior extensive abdominal surgery. Using a computer-generated randomization table, participants will be allocated in a 1:1 ratio to either the ERAS or TCP arm. The allocation will occur after informed consent from parents or guardians.

ERAS arm:

Pre-operative preparation consists of two rectal enemas and oral laxative 12 hours apart on the day before surgery.

Clear oral fluids are allowed until three hours prior to anesthesia.

Intraoperative management includes minimal bowel handling and caudal block for pain control.

Postoperative care features avoidance of opioid analgesia, removal of nasogastric tube within 48 hours, and initiation of clear oral fluids followed by early progression to solid diet as tolerated.

Traditional Care arm:

Mechanical bowel preparation and clear fluid diet for three days before surgery.

Overnight fasting and intra-venous antibiotics are given.

Postoperative management includes routine nasogastric decompression with a nil-per-mouth regimen for at least three days, opioid analgesia, and gradual reintroduction of oral intake starting on postoperative day three or four.

All operations will be performed by consultant pediatric surgeons with at least five years of post-FCPS experience to ensure procedural consistency.

Data Collection and Analysis

Daily postoperative assessments will include vital signs, abdominal examination, and tolerance of oral intake. Laboratory evaluation on postoperative day one will include complete blood count and serum electrolytes, with corrections as indicated. The primary endpoint is length of hospital stay, defined as the number of days from surgery to discharge once the child consumes at least one age-appropriate solid meal without vomiting for six hours. Data will be entered in SPSS version 25. Quantitative variables will be summarized as means and standard deviations; qualitative variables as frequencies and percentages. Independent-sample t tests will compare the primary outcome between groups. Age, gender, and underlying diagnosis will be assessed as potential effect modifiers through stratification followed by post-stratification t tests. A p-value ≤0.05 will be considered statistically significant.

Significance

This study addresses a key evidence gap by providing randomized controlled data on ERAS in a high-volume pediatric surgical setting in Punjab, Pakistan. Demonstrating a reduction in hospital stay without added complications could support broader adoption of ERAS protocols, improving patient turnover, reducing healthcare costs, and enhancing recovery for children undergoing colostomy reversal.

Being tested
Enhanced Recovery after Surgery Protocol, Traditional Care Protocol
Keywords
Pediatric Colostomy, Colostomy Reversal, Enhanced Recovery After Surgery, ERAS, Traditional Care protocol, Length of Hospital Stay

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Enhanced Recovery after Surgery ProtocolOther

    Also called ERAS

    reduced fasting, no mechanical bowel prep, early feeding, non-opioid analgesia.

  • Traditional Care ProtocolOther

    Participants receive standard peri-operative management for colostomy reversal. This includes three days of mechanical bowel preparation with oral laxatives and clear fluids, overnight fasting before surgery, routine nasogastric tube placement, opioid-based postoperative pain control, and a nil-per-mouth regimen for at least three days after surgery before gradually resuming oral intake.

Study groups in NCT07206836
Study groupRoleWhat they receive
Enhanced Recovery after Surgery (ERAS)ExperimentalPatients undergoing colostomy reversal managed with the Enhanced Recovery After Surgery (ERAS) protocol, which emphasizes reduced fasting, avoidance of mechanical bowel preparation, early postoperative oral feeding, and multimodal non-opioid analgesia.
Receives: Other: Enhanced Recovery after Surgery Protocol
Traditional Care ProtocolActive comparatorPatients undergoing colostomy reversal managed with the traditional perioperative care protocol, including three days of mechanical bowel preparation, overnight fasting before surgery, routine nasogastric tube placement, opioid-based postoperative pain control, and delayed resumption of oral intake.
Receives: Other: Traditional Care Protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Length of Hospital Stay (Days)

    Duration of hospitalization measured from the day of surgery until discharge.

    Measured: From date of surgery through hospital discharge (an average of 3-14 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2025
  2. Study start1 Aug 2025
  3. Primary completionNov 2025 (estimated)
  4. Study completionNov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07206836
Sponsor's protocol ID
696/CH&ICH/FSD
Status last verified
Sep 2025
First submitted
13 Sep 2025
Last updated
3 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Age, Gender, Diagnosis, Arm of study, Length of Hospital Stay

Questions about this trial

What is this clinical trial studying?

A study testing Enhanced Recovery after Surgery Protocol and Traditional Care Protocol in people with Colostomy - Stoma and Stoma Reversal Procedure, run by Children Hospital Faisalabad at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Salman Ali, MBBS (+923000680882, SalmanAli@live.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Length of Hospital Stay (Days) (time frame: From date of surgery through hospital discharge (an average of 3-14 days)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in